Automated medication workflows call for structured, AI-ready intelligence

In an environment of rising clinical complexity and persistent burnout, healthcare organizations can’t afford medication workflows that are fragmented or inconsistent. They are looking to automate workflows, from medication reconciliation to drug screening and cost checks. AI agents represent an opportunity to streamline and automate.

The next era of medication intelligence begins now.

Medi-Span Expert AI delivers medication intelligence for the AI-driven workflows your teams are developing. Built on decades of Medi-Span® expertise, Medi-Span Expert AI delivers Medi-Span medication content in a way that helps AI more easily understand. Medi-Span Expert AI powering your agentic AI solutions delivers:

  • Structured, evidence-based medication intelligence designed for AI use.
  • Logic and tools that help guide how AI interprets and applies medication intelligence.
  • Clear visibility into the medication content AI systems leverage to inform tasks.
Read The Announcement
Read The Announcement

Model Context Protocol

Model Context Protocol (MCP) makes Medi-Span drug data available to AI-powered workflows in a structured, AI-ready format that supports scalable automation.

Expert-curated content

Rigorous expert review processes help to keep Medi-Span medication intelligence current, consistent, and aligned with evidence-based standards.

Scalable development

Our MCP approach enables Medi-Span medication intelligence to be integrated and leveraged across multiple AI-driven workflows and agents, supporting AI initiatives to scale.
Abstract bright light in motion background

How Model Context Protocol supports the future of agentic healthcare

Agentic AI should be grounded in evidence-based content to support decision logic within clinical workflows. Without medication intelligence, agents rely on generic large language models, which can introduce variability and the potential for inaccurate guidance.
Read More
Abstract digital technology background

Earning trust in the AI era

This practical guide examines how digital health technology companies can design credible products for real healthcare workflows as AI-enabled functionality becomes easier to build. Digital health experiences need to support users with trusted clinical guidance, reliable therapeutic and medication intelligence, and patient-facing education.
Download The eBook
Closeup network connection on a dark background

Medication intelligence is the backbone of scalable health tech

To support AI readiness in healthcare, digital health tech developers need drug data layers that provide both trusted content and structured outputs. In this whitepaper from Wolters Kluwer and Fierce Healthcare, we explore how solutions with a trusted intelligence foundation can support both innovation and collaboration across the healthcare ecosystem.
Get The Whitepaper

Ready to advance medication workflows with reliable, AI-ready intelligence?

Speak to a specialist to explore how Medi-Span Expert AI can help cut development timelines and provide an intelligent and reliable foundation for medication workflows.
Speak To An Expert

  • Why choose Medi-Span

  • Why medication intelligence AI matters

What customers are saying about Medi-Span evidence-based drug data

Satisfaction

98% of customers are satisfied with the quality of Medi-Span data

Renewal rate

99% of customers are likely to renew their Medi-Span data license

Productivity

50% or greater increase in productivity reported by hundreds of Medi-Span customers
Female doctor talking with female patient in doctor's office

Healthcare doesn’t need more AI – it needs evidence-based AI

New data from Wolters Kluwer highlights a growing risk: 17% of healthcare staff use unauthorized AI tools.

Challenge #1 – General-purpose AI solutions continue to struggle with basic medication safety tasks1:

  • Drug formulation matching: 49% accuracy with 1.14 hallucinations per medication
  • Drug–drug interaction ID: 54.7% accuracy
  • Medication-order generation: 34% error rate

Challenge #2 – Even consumer-grade health AI tools struggle2:

  • Failure to provide appropriate triage recommendations for 35% of non-urgent presentations
  • Under-triaging 52% of emergencies

When general-purpose LLMs fall short, Medi-Span Expert AI integrates advanced AI with evidence-based drug data to deliver the rigor required in environments where patient safety is nonnegotiable.

Speak with a Medi-Span expert

With the rapid growth of agentic AI in healthcare, we’d welcome the opportunity to speak with you about your development and innovation needs. Let’s start a conversation to explore:

  • The role that AI agents can play in your tech innovation.
  • How MCP provides efficiency and confidence in your agentic AI builds.
  • The difference that credible and reliable drug data will have on powering your solutions and healthcare workflows.

Expert Insights

사우디 아라비아의 Sariryah Medical Company는 어떻게 Wolters Kluwer의 근거 기반의 자료를 사용하여 효율적인 고품질 의료 서비스를 제공하는가?
Health
1월 01, 2025

사우디 아라비아의 Sariryah Medical Company는 어떻게 Wolters Kluwer의 근거 기반의 자료를 사용하여 효율적인 고품질 의료 서비스를 제공하는가?

투약 오류를 줄이고 임상 의사결정 지원의 가치를 극대화하기 위해 개선된 처방
Health
1월 01, 2025

투약 오류를 줄이고 임상 의사결정 지원의 가치를 극대화하기 위해 개선된 처방

  1. https://arxiv.org/pdf/2509.22926
  2. https://www.nature.com/articles/s41591-026-04297-7
Back To Top